| |
Antidiabetic medication
|
Use of statins
|
|---|
|
Metforminb
|
Other oral ADMb
|
Metformin and other oral ADMb
|
Insulin
|
No use of ADM
|
Yesb
|
No
|
Total
|
|---|
|
Number of patients
|
77
|
58
|
100
|
82
|
104
|
186
|
235
|
421
|
|
Age at diagnosis, years
|
|
Median
|
69
|
75
|
70
|
71
|
72
|
71
|
71
|
71
|
|
IQRc
|
63─77
|
66─80
|
61─77
|
65─78
|
64─79
|
65─77
|
62─78
|
64─78
|
|
Age categories, years (%)
|
|
42─59
|
8 (10)
|
6 (10)
|
19 (19)
|
9 (11)
|
17 (16)
|
18 (10)
|
41 (17)
|
59 (14)
|
|
60─69
|
33 (43)
|
13 (22)
|
31 (31)
|
28 (34)
|
27 (26)
|
66 (35)
|
66 (28)
|
132 (31)
|
|
70─79
|
30 (39)
|
24 (41)
|
42 (42)
|
29 (35)
|
35 (34)
|
74 (40)
|
86 (37)
|
160 (38)
|
|
80─92
|
6 (8)
|
15 (26)
|
8 (8)
|
16 (20)
|
25 (24)
|
28 (15)
|
42 (18)
|
70 (17)
|
|
Duration of T2D, years (%)
|
|
Median
|
3.1
|
5.0
|
6.2
|
10.8
|
7.0
|
6.3
|
5.7
|
6.2
|
|
IQRc
|
2.0─5.5
|
3.1─8.3
|
4.1─8.9
|
6.8─15.0
|
2.0─10.1
|
3.1─10.0
|
3.1─10.0
|
3.1─10.1
|
|
0.5 ─ < 3
|
37 (48)
|
15 (26)
|
13 (13)
|
4 (5)
|
34 (33)
|
45 (24)
|
58 (25)
|
103 (24)
|
|
3 ─ < 6
|
24 (31)
|
20 (34)
|
30 (30)
|
13 (16)
|
13 (12)
|
40 (22)
|
60 (26)
|
100 (24)
|
|
6 ─ < 12
|
14 (18)
|
19 (33)
|
44 (44)
|
30 (37)
|
41 (39)
|
71 (38)
|
77 (33)
|
148 (35)
|
|
12 ─ < 34
|
2 (3)
|
4 (7)
|
13 (13)
|
35 (43)
|
16 (15)
|
30 (16)
|
40 (17)
|
70 (17)
|
|
Stage (%)
|
|
Local
|
14 (18)
|
6 (10)
|
11 (11)
|
11 (13)
|
10 (10)
|
24 (13)
|
28 (12)
|
52 (12)
|
|
Advanced
|
58 (75)
|
45 (78)
|
77 (77)
|
64 (78)
|
86 (83)
|
142 (76)
|
188 (80)
|
330 (78)
|
|
Unknown
|
5 (6)
|
7 (12)
|
12 (12)
|
7 (9)
|
8 (8)
|
20 (11)
|
19 (8)
|
39 (9)
|
- aThe entries are number and percentages (in parenthesis) if not otherwise stated
- bDuration of medication ≥180 days
- cInterquartile range
